lapaʻau renal cell carcinoma pathology outlines

ʻO ka mālama ʻana i ka maʻi maʻi maʻi maʻi maʻi ʻaʻai: kahi ʻano maʻi maʻi e hoʻomaopopo i ke ʻano o ka maʻi maʻi maʻi maʻi maʻi: he alakaʻi piha ʻo Renal cell carcinoma (RCC), ke ʻano maʻamau o ka maʻi maʻi maʻi ʻaʻai, hōʻike i nā hiʻohiʻona pathological like ʻole e pili ana i nā hoʻolālā lapaʻau. Hōʻike kēia alakaʻi i nā mea nui o lapaʻau renal cell carcinoma pathology outlines, kōkua i ka hoʻomaopopo ʻana i ka ʻike a me ka hoʻokele. No ka hoʻonaʻauao kēia ʻike a ʻaʻole ia he ʻōlelo aʻoaʻo olakino. Kūkākūkā mau me kekahi ʻoihana mālama ola no nā pilikia olakino.

Hoʻokaʻawale i ka maʻi maʻi maʻi maʻi maʻi

Nā ʻano subtype mōʻaukala

Hōʻike ʻo RCC i nā subtypes histological like ʻole, kēlā me kēia me nā hiʻohiʻona kūʻokoʻa e pili ana i ka prognosis a me ka mālama ʻana. ʻO ka mea nui loa, ʻo ia ka RCC cell clear (ccRCC), i hōʻike ʻia e ka cytoplasm maʻemaʻe ma muli o ka glycogen a me ka hōʻiliʻili lipid. ʻO nā subtypes koʻikoʻi ʻē aʻe e pili ana i ka papillary RCC (pRCC), chromophobe RCC (chRCC), a me ka duct RCC (cdRCC). ʻOkoʻa kēia mau ʻano subtypes i kā lākou hoʻololi genetic, nā ʻano ulu, a me nā pane i ka lāʻau lapaʻau. He mea koʻikoʻi ka hoʻokaʻawale pololei ʻana no ke alakaʻi ʻana lapaʻau renal cell carcinoma pathology outlines. No ka ʻike kikoʻī hou aku e pili ana i kēia mau subtypes, e ʻimi i nā kumuwaiwai pathology kaulana.

Ka helu ʻana a me ke kau ʻana

Nānā ka ʻōnaehana helu Fuhrman i ka helu nuklea o RCC, e hōʻike ana i ka ikaika o ka ʻōpū. Hoʻopili ʻia nā māka kiʻekiʻe me ka wānana maikaʻi ʻole. ʻO Staging, me ka hoʻohana ʻana i ka ʻōnaehana TNM (Tumor, Node, Metastasis), wehewehe i ka nui o ka laha ʻana o ka maʻi tumora, koʻikoʻi no ka hoʻoholo ʻana i nā ala lapaʻau. He mea nui ka hoʻomaopopo piha ʻana i ka mākaʻikaʻi ʻana a me ke kau ʻana no ka hoʻolālā lapaʻau maikaʻi. ʻO ka pae kūpono a me ka papa e hoʻoikaika nui i kāu lapaʻau renal cell carcinoma pathology outlines.

Molecular Pathology and Targeted Therapies

Hoʻololi Genetic

ʻO nā hoʻololi genetic kikoʻī a me nā hoʻololi e alakaʻi i ka hoʻomohala a me ka holomua o RCC. ʻIke pinepine ʻia ka VHL (von Hippel-Lindau) gene inactivation i ka ccRCC, e alakaʻi ana i ka hoʻoulu ʻana o ke ala hypoxia-inducible factor (HIF). ʻO ka hoʻomaopopo ʻana i kēia mau mea hoʻokele genetic e maʻalahi ke koho ʻana i nā lāʻau lapaʻau. ʻO ka ʻike ʻana i kēia mau ʻokoʻa genetic hiki ke kōkua i ka hana kikoʻī hou aku lapaʻau renal cell carcinoma pathology outlines.

ʻO ka Lapaʻau Kūlohelohe

Hoʻohana nā lāʻau lapaʻau i hoʻopaʻa ʻia i kēia mau nāwaliwali genetic, koho koho i nā ala molekala kūikawā e pili ana i ka ulu ʻana o ka maʻi tumora. ʻO nā laʻana he tyrosine kinase inhibitors (TKIs), e like me ka sunitinib a me ka pazopanib, e kuhikuhi ana i nā mea hoʻokipa vascular endothelial growth factor (VEGF). ʻO kēia mau lāʻau lapaʻau he ʻāpana pinepine ia o ka hoʻolālā lapaʻau e pili ana i ka kikoʻī lapaʻau renal cell carcinoma pathology outlines ʻike ʻia.

Immunohistochemistry (IHC) ma RCC

He kuleana koʻikoʻi ko IHC i ka ʻike ʻana a me ka hoʻopili ʻana i ka RCC. Hiki i nā māka e like me CD10 a me vimentin ke kōkua i ka hoʻokaʻawale ʻana i nā subtypes RCC. Hoʻohana pū ʻia ʻo IHC e loiloi i nā biomarkers e wānana i ka pane ʻana i ka lāʻau lapaʻau.

ʻO ke kiʻi kiʻi ma ka hōʻike ʻana a me ka nānā ʻana i ka mālama ʻana

ʻO nā ʻenehana kiʻi e like me CT scans a me MRI scans e hāʻawi i ka ʻike koʻikoʻi e pili ana i ka nui o ka tumo, kahi, a me ka metastasis. He mau mea koʻikoʻi kēia i ka hana ʻana i nā kikoʻī lapaʻau renal cell carcinoma pathology outlines. Hoʻohana ʻia ke kiʻi maʻamau e nānā i ka pane ʻana o ka lāʻau a ʻike i ka hoʻi hou ʻana.

Nā Kūlana Lapaʻau

ʻO ke koho ʻana o ka lāʻau lapaʻau e pili ana i nā kumu he nui, e pili ana i ka pae tumo, ka pae, a me nā ʻano maʻi. ʻO nā koho e pili ana i ka hōʻoki ʻana, ka lāʻau lapaʻau i manaʻo ʻia, immunotherapy, a me ka radiation therapy. Hoʻoholo ʻia ke ala maikaʻi loa e ka noʻonoʻo pono ʻana i nā kikoʻī lapaʻau renal cell carcinoma pathology outlines.

ʻO ke kuleana o Shandong Baofa Cancer Research Institute

No ka mālama 'ana i ka ma'i 'a'ai piha, me ka hiki 'ana o ka diagnostics ki'eki'e a me nā ho'olālā lapa'au pilikino no ka ma'i 'a'ai ma'i ma'i, e no'ono'o i ke akamai o ka Shandong Baofa Cancer Research Institute. E aʻo hou aʻe e pili ana i kā lākou noiʻi holomua a me ka hoʻokō ʻana i ka mālama maʻi ma ke kipa ʻana i kā lākou pūnaewele: https://www.baofahospital.com/. ʻO kā lākou nānā ʻana i ka noiʻi ʻokiʻoki e pili pono i ka hoʻomohala ʻana o ka hoʻomaikaʻi lapaʻau renal cell carcinoma pathology outlines.

Papa Hōʻuluʻulu: RCC Subtypes

Subtype	Nā hiʻohiʻona	Ka wānana
Hoʻomaʻemaʻe Cell RCC	Maʻemaʻe cytoplasm, VHL gene inactivation	Hoʻololi, pili pinepine me ka metastasis
Papillary RCC	ʻO ka hoʻolālā papillary, nā hoʻololi MET	Maikaʻi maʻamau
Chromophobe RCC	Pale cytoplasm, ʻano morphology	Maikaʻi maʻamau

Hōʻole: No ka hoʻonaʻauao wale nō kēia ʻike a ʻaʻole pono e manaʻo ʻia he ʻōlelo aʻoaʻo olakino. E kūkākūkā mau me kekahi ʻoihana mālama ola kūpono no ka hōʻoia ʻana a me ka mālama ʻana i kekahi maʻi olakino.